MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Vericel Corporation DSO Ratio 2011-2025 | VCEL
Annual DSO Ratio Vericel Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.1 | 96.9 | 93.2 | 84.1 | 98 | 99.6 | 94.2 | 104 | 115 | 77.9 | 104 | - | 487 | 182 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 487 | 77.9 | 133 |
Quarterly DSO Ratio Vericel Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 | 84.5 | 99.1 | - | 76 | 84.8 | 96.3 | - | 78.1 | 76.2 | 94.4 | - | 40.6 | 39.2 | 87.6 | - | 80.2 | 70.3 | 84 | 69.6 | 97.6 | 157 | 114 | 74.5 | 96.2 | 112 | 116 | 68.3 | 95.2 | 113 | 106 | 71.4 | 117 | 98.3 | 172 | 94.4 | 143 | 122 | 90.6 | 64.6 | 88.1 | 73.3 | 80.4 | 50.8 | 77.4 | 169 | - | - | - | 122 | 160 | 88.8 | 411 | 456 | 456 | - | 91.2 | 91.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 456 | 39.2 | 116 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.89 | 3.82 % | $ 812 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.22 | -1.08 % | $ 249 M |  USA |
 |
Aptevo Therapeutics
APVO
|
79 | $ 1.07 | -5.31 % | $ 295 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
132 | $ 213.6 | -3.09 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.1 | -5.53 % | $ 7.46 B |  Australia |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.35 | 4.25 % | $ 1.28 B | USA |
 |
Anika Therapeutics
ANIK
|
77.3 | $ 9.62 | 0.63 % | $ 141 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.26 | -8.44 % | $ 566 M |  Israel |
 |
Catalyst Biosciences
CBIO
|
3.24 | $ 13.28 | -5.78 % | $ 874 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Axon Enterprise
AXON
|
134 | $ 550.6 | -2.43 % | $ 41.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
150 | $ 2.37 | 3.04 % | $ 14.9 M | USA |
 |
Celldex Therapeutics
CLDX
|
86.5 | $ 27.0 | -1.85 % | $ 1.74 M | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.3 | -2.04 % | $ 731 M | USA |
 |
Biogen
BIIB
|
57.9 | $ 175.09 | 0.57 % | $ 25.5 B | USA |
 |
Abeona Therapeutics
ABEO
|
387 | $ 5.07 | -5.5 % | $ 108 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
25.7 | $ 87.9 | -0.1 % | $ 9.07 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
44.2 | $ 24.31 | 2.92 % | $ 2.88 B | USA |
 |
ADiTx Therapeutics
ADTX
|
621 | $ 1.6 | -28.57 % | $ 21.1 K | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | USA |